India Approves Use of Single-Dose Sputnik Light Vaccine | News

The Russian Direct Investment Fund (RDIF) announced that the Indian authorities registered for emergency use the Russian vaccine against the virus that causes Covid-19, a single dose, Sputnik Light.

READ ALSO:

Study reveals that Sputnik V is the best vaccine against Covid-19

“The RDIF announces the registration by the General Medicines Center of India of the one-component vaccine against the coronavirus Sputnik Light,” the Fund published in a statement.

According to this entity, Sputnik Light is present in more than 30 countries, with a total population of more than 2,500 million people.

The immunizer, known to be a single-dose version of Sputnik V, was developed by the Nikolai Gamaleya Center for Epidemiology and Microbiology in cooperation with the RDIF.



Its design consists of a human adenovirus type 26, and among its advantages is the ability to increase the efficacy, in addition to the duration of other vaccines if it is used as a booster.

Additional clinical trials with the vaccine have already been carried out in India, which were taken into account for approval by the authorities.

The executive director of the RDIF, Kirill Dimitriev, assured that the authorization of Sputnik Light in India is “another important step in the successful cooperation between Russia and India in the fight against Covid-19”.

“Sputnik Light has been shown to be safe and effective both as a stand-alone vaccine and as a universal vaccine booster with other producers, helping to induce a stronger immune response compared to two injections of the same vaccine,” he added.

In addition, in this Asian nation, since April 2020 it has approved the use of Sputnik V and is the main country that produces the Russian immunizer.

Other countries such as Argentina, Bahrain, the United Arab Emirates, San Marino and the Philippines have already authorized Sputnik Light as a universal booster.